Upload Avatar (500 x 500)
Ke Su
Medical School
Wuhan University
Hubei
Language: Chinese, English
Diabetes
Nephropathy
Pathogenesis
Chronic
Renal Failure
Diagnosis
Treatment
Kidney Disease
Clinical Research
Medical Science
Areas of Focus
- Pathogenesis of diabetic nephropathy
- Diagnosis and treatment of chronic renal failure
Work Experience
- 2013-2019: Attending Physician, Nephrology Department, Renmin Hospital, Wuhan University
- 2020-present: Associate Senior Doctor, Nephrology Department, Renmin Hospital, Wuhan University
- 2021-present: Visiting Scholar, University of Montreal, Canada
Academic Background & Achievements
- 2003-2008: Bachelor of Clinical Medicine from Wuhan University
- 2008-2013: PhD in Pathophysiology from Wuhan University
- Received a National Natural Science Fund
Publications
- Liraglutide attenuates renal tubular ectopic lipid deposition in rats with diabetic nephropathy by inhibiting lipid synthesis and promoting lipolysis, Su Ke, 2020
- How we mitigated and contained the COVID-19 outbreak in a hemodialysis center: Lessons and experience, Su Ke, 2020
- FTY720 Attenuates Angiotensin II-Induced Podocyte Damage via Inhibiting Inflammatory Cytokines, Su Ke, 2017
- Tumor suppressor berberine binds VASP to inhibit cell migration in basal-like breast cancer, Su Ke, 2016
- PCB77 Inducing Renal Tubular Cell Apoptosis, Su Ke, 2015
- Matrine inhibits the adhesion and migration of BCG823 gastric cancer cells by affecting the structure and function of the vasodilator-stimulated phosphoprotein (VASP), Su Ke, 2013
- HIF-1alpha acts downstream of TNF-alpha to inhibit vasodilator-stimulated phosphoprotein expression and modulates the adhesion and proliferation of breast cancer cells, Su Ke, 2012
